Section 3.6: Saudi Pharmacy Law & SFDA Regulations

Saudi Pharmacy Law & SFDA Regulations

The Regulatory Framework of the SFDA

The Saudi Food and Drug Authority (SFDA) regulates the safety, quality, efficacy, and pricing of drugs, medical devices, food, and cosmetics within the Kingdom of Saudi Arabia. No pharmaceutical product can be imported, manufactured, or distributed in Saudi Arabia without being registered and approved by the SFDA.

• Drug Registration Pathways: The SFDA categorizes drug registration into distinct files, including innovative products (new chemical entities), generics, biosimilars, and herbal products.
• Pricing Mandate: The SFDA strictly regulates the public and private sector pricing of all registered medications, setting a fixed retail price (Public Selling Price - PSP) that must be displayed on the product packaging.

Controlled Drug Regulations in Saudi Arabia

The regulation of controlled substances in Saudi Arabia is governed by strict laws aimed at preventing addiction, diversion, and misuse while ensuring therapeutic availability. Controlled drugs are classified into distinct schedules based on their potential for abuse and therapeutic utility. Pharmacists must be familiar with the Law of Combatting Narcotics and Psychotropic Substances.

Narcotics, Psychotropics, and Semi-Controlled Substances

These substances are subject to the highest level of security, documentation, and specific record-keeping requirements:

• Prescribing Authority: Controlled substances can only be prescribed by registered physicians with specialized licenses (consultants or specialists) within their scope of practice.
• Controlled Prescription Forms: Prescriptions for narcotics and psychotropics must be written on specialized, serial-numbered, duplicate/triplicate colored prescription forms (traditionally pink for narcotics) or verified electronic equivalents. The pharmacist must file the copy and log it in the pharmacy's official controlled substance ledger.
• Required Data Fields: The prescription must contain the patient's full name, National ID or Iqama (residence permit) number, age, diagnosis, drug name (scientific/generic name), strength, dosage form, instructions, quantity in digits and words, prescriber stamp, and signature.
• Semi-Controlled Substances: Medications like pregabalin and gabapentin are classified as semi-controlled in Saudi Arabia due to their high local potential for misuse. They require standard prescription forms, but are tracked with mandatory documentation of the patient's national ID and cannot be refilled without a new medical order.
• Validity & Quantity Limits:
  • Narcotic Prescriptions: Valid for only 3 days (72 hours) from the date of issue. The maximum supply limit is 30 days for chronic pain conditions (managed by oncology or palliative care) and 3 days for acute pain.
  • Psychotropic Prescriptions: Valid for 7 days from the date of issue. The maximum supply limit is typically 30 days for chronic conditions.
• Disposal of Controlled Substances: The disposal of expired or damaged controlled drugs requires strict coordination. It must be conducted in the presence of an MOH representative and a designated pharmacist-in-charge as witnesses, with formal signatures on a destruction log to prevent diversion.

Prescription Validation and Dispensing

Pharmacists bear the legal responsibility to validate all prescriptions before dispensing:

• Refills: Refills are prohibited for narcotics and psychotropic prescriptions. Chronic medications (non-controlled) can have refill schedules clearly documented by the physician, up to a maximum of one year.
• Scientific/Generic Name Prescribing: Saudi law mandates that physicians prescribe medications by their scientific (generic) name. Pharmacists may perform generic substitution if the brand prescribed is unavailable, provided the patient is informed and the product has equivalent SFDA registration and therapeutic equivalence.
• Tele-pharmacy and E-prescribing: Electronic prescriptions issued via approved Ministry of Health platforms (such as Sehhaty or Wasfaty) must be verified through two-factor authentication and are subject to the same validation laws as physical prescriptions.

Pharmacy and Pharmacist Licensing

Pharmacy operations and professional practice are governed by licensing standards set by both the MOH and the Saudi Commission for Health Specialties (SCFHS):

• Pharmacy Licensing: Community and hospital pharmacies must obtain operational licenses from the MOH and comply with SFDA regulations regarding storage temperatures (e.g., 2–8°C for refrigerators, 15–25°C for room temperature), security for controlled cabinets (including heavy-gauge dual-lock safes connected to central hospital alarm systems), and clean room standards. Violations of these pharmacy practice laws can result in severe administrative penalties, including fines up to 100,000 SAR, suspension, or license revocation.
• Pharmacist Licensing: To practice pharmacy in Saudi Arabia, graduates must pass the Saudi Pharmacist Licensure Examination (SPLE). Upon passing, they are registered and classified by the SCFHS.
• Licensing Renewal: To maintain registration, pharmacists must complete a mandated number of Continuous Professional Development (CPD) hours (usually 20 hours per year) and show no history of ethical violations.

Summary of Saudi Controlled Prescription Rules